Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider. Viona is marketing and distributing a strong portfolio of oral solids and topicals and has a vast number of products in the development pipeline, which we are excited to introduce to the market in due time! To see the products that we have already introduced into the market, please see our list of products.
Viona has built a team of experienced and committed professionals in all aspects of the business and we have ambitious growth plans for our company.
Our mission is to provide our customers with high quality, affordable generic products with an excellent service level.
Viona Incorporated
Viona launches Metronidazole Tablets, USP 250mg & 500mg
Viona launches Voriconazole Tablets 50mg & 200mg
Viona launches Doxycycline Hyclate Tablets, USP 100mg
Viona launches Memantine Hydrochloride Tablets, USP 5mg & 10mg and Metformin Hydrochloride Tablets Extended-Release Tablets, USP 750mg
Viona launches Ranolazine Extended-Release Tablets 500mg & 1,000mg
Viona launches Acyclovir Ointment, USP 5% and Desonide Cream 0.05%
Viona launches Betamethasone Dipropionate Ointment, USP 0.05% and Fluocinonide Cream, USP 0.1%
Viona launches Nystatin Ointment, USP 100,000 units Per Gram
Viona launches Desoximetasone Ointment, USP 0.025%
Viona launches Triamterene and Hydrochlorothiazide Capsules, USP 37.5 mg/25 mg, Nystatin and Triamcinolone Acetonide Ointment USP, Desoximetasone Cream, USP 0.25%, and Acyclovir Capsules, USP 200 mg
Viona launches Felbamate Tablets, USP 400 mg & 600 mg, and Clindamycin Phosphate Topical Solution, USP 1%
Viona launches Doxycycline Hyclate Capsules, USP 50 mg & 200 mg
Viona launches Modafinil Tablets, USP 100 mg & 200 mg
Viona launches Aripiprazole Orally Disintegrating Tablets, USP 10 mg & 15 mg
Viona launches Zonisamide Capsules, USP 25 mg, 50 mg & 100 mg
Viona launches Clobetasol Propionate Lotion, 0.05%
Viona launches Tizanidine Tablets, USP 2 mg & 4 mg
Viona launches Mirtazapine Orally Disintegrating Tablets, USP 15 mg, 30 mg & 45 mg
Viona launches Bisoprolol Fumarate Tablets, USP 5 mg & 10 mg
Viona launches Acyclovir Cream, 5%
Viona launches Tavaborole Topical Solution, 5%
Viona launches Ivermectin Cream, 1%
Viona launches Loperamide Hydrochloride Capsules, USP 2 mg
Viona launches Sucralfate Tablets, USP 1 gram
Viona launches Febuxostat Tablets, 40 mg and 80 mg
Viona launches Acetazolamide Tablets, USP 125 mg and 250 mg
Viona launches Clindamycin Phosphate Gel, USP 1%
Viona launches Bisoprolol Fumarate and Hydrochlorothiazide, USP 2.5 mg/6.25 mg, 5 mg/6.25 mg and 10 mg/6.25 mg
Viona launches Dapsone Gel, 7.5%
Viona launches Darunavir Tablets, 600 mg and 800 mg
Viona launches Dexamethasone Tablets, USP 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg
Viona launches Dexamethasone Tablets, USP 1 mg
Viona launches Dexamethasone Tablets, USP 2 mg
Viona launches Theophylline Extended-Release Tablets, 300 mg and 450 mg
Viona launches Valsartan Tablets, USP 40 mg, 80 mg, 160 mg and 320 mg